la jolla Archives - MedCity News

Neuro Startup Arialys Raises $58M for Privilege of Tackling Brain Inflammation

Frank Vinluan — Tue, 12 Sep 2023 21:28:52 +0000

Avalon BioVentures unveiled new portfolio company Arialys Therapeutics. The startup’s lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder.

Turnstone Bio Goes IPO to Fund Clinical Tests of New Kind of Cancer Cell Therapy

Frank Vinluan — Fri, 21 Jul 2023 16:04:46 +0000

Turnstone Biologics isn’t the only cell therapy biotech focused on tumor-infiltrating lymphocytes. With $80 million in IPO cash, it can continue clinical trials that could show whether its approach to TILs has advantages.

Aira takes its Google Glass navigation for visually impaired to non-U.S. markets

Stephanie Baum — Fri, 18 May 2018 16:05:54 +0000

In addition to airports, the company’s Google Glass-enabled technology has been used to help individuals navigate college campuses, train stations, and city centers.

An employer benefits adviser has launched a genomic testing advisory business

Stephanie Baum — Fri, 18 Aug 2017 17:11:18 +0000

The goal of the La Jolla, California-based company, is to make genomic testing readily accessible and affordable for everyone through employer plans.

Venter steps down as CEO of Human Longevity

Juliet Preston — Wed, 04 Jan 2017 21:27:32 +0000

J. Craig Venter will step down as CEO of his ambitious genomics-driven biotech Human Longevity, effective January 9.

Making up for scrapped IPO, melanoma diagnostics company DermTech raising $20M

Meghana Keshavan — Fri, 14 Aug 2015 17:33:50 +0000

DermTech has a biopsy-free approach to test for melanoma – using an adhesive patch to collect skin cells and test if the RNA expression is consistent with cancer.

West Health CEO retiring; here’s what he’s accomplished

Neil Versel — Tue, 07 Jul 2015 19:08:00 +0000

Nick Valeriani will retire as CEO of West Health in September, and be replaced by current COO Shelley Lyford, who also is president and CEO the Gary and Mary West Foundation, the entity that sponsors West Health.

Translational medicine: Sanford-Burnham gets $100M donation

Meghana Keshavan — Wed, 24 Jun 2015 21:06:04 +0000

The research institute already has strong ties with the pharmaceutical industry.

This donation is reflective of an overall increase in translational medicine – in these changing times, the biopharma industry has a growing reliance on academia